Click Here to return To Results

 

Inhibition of CD40L with Frexalimab in Multiple Sclerosis NEJM 390:589-600, 662, Vermersch,P.,et al, 2024 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) biologic markers efficacy frexalimab monoclonal antibodies MRI,abnormal MRI,contrast enhanced multiple sclerosis multiple sclerosis,treatment of neurofilament light chain protein safety

Click Here to return To Results